49 related articles for article (PubMed ID: 34980493)
1. Prostate cancer risk prediction based on complete prostate cancer family history.
Albright F; Stephenson RA; Agarwal N; Teerlink CC; Lowrance WT; Farnham JM; Albright LA
Prostate; 2015 Mar; 75(4):390-8. PubMed ID: 25408531
[TBL] [Abstract][Full Text] [Related]
2. A Latent Disease Model to Reduce Detection Bias in Cancer Risk Prediction Studies.
Aleshin-Guendel S; Lange J; Goodman P; Weiss NS; Etzioni R
Eval Health Prof; 2021 Mar; 44(1):42-49. PubMed ID: 33506704
[TBL] [Abstract][Full Text] [Related]
3. Modifiable risk factors for subsequent lethal prostate cancer among men with an initially negative prostate biopsy.
Feng X; Zhang Y; Vaselkiv JB; Li R; Nguyen PL; Penney KL; Giovannucci EL; Mucci LA; Stopsack KH
Br J Cancer; 2023 Dec; 129(12):1988-2002. PubMed ID: 37898724
[TBL] [Abstract][Full Text] [Related]
4. Re: Outcomes of Biopsy Grade Group 1 Prostate Cancer Diagnosis in the Danish Population.
Montironi R; Cimadamore A; Giannarini G; Crestani A; Lopez-Beltran A; Cheng L
Eur Urol; 2024 Jun; 85(6):589-590. PubMed ID: 38490852
[No Abstract] [Full Text] [Related]
5. BioPrev-C - development and validation of a contemporary prostate cancer risk calculator.
Hermanns T; Wettstein MS; Kaufmann B; Lautenbach N; Kaufmann E; Saba K; Schmid FA; Hötker AM; Müntener M; Umbehr M; Poyet C
Front Oncol; 2024; 14():1343999. PubMed ID: 38450183
[TBL] [Abstract][Full Text] [Related]
6. Positive family history as a predictor for disease outcomes after radical prostatectomy for nonmetastatic prostate cancer.
Rajwa P; Quhal F; D'Andrea D; Korn S; Petrov P; Yanagisawa T; Kawada T; Motlagh RS; Mostafaei H; Laukhtina E; Aydh A; König F; Pallauf M; Pradere B; Nyirády P; Abufaraj M; Marra G; Gandaglia G; Briganti A; Karakiewicz P; Ye DW; Haydter M; Chlosta P; Comperat E; Enikeev D; Shariat SF
Arab J Urol; 2023; 21(4):241-247. PubMed ID: 38178943
[TBL] [Abstract][Full Text] [Related]
7. Checkpoint Kinase 2 (CHEK2) Gene Mutation in a Patient With Breast and Prostate Cancer: A Unique Presentation of a Rare Disease.
Ekram SN; Al Shanbari N; Bin Laswad BM; Alharthi A; Tayeb W; Bahha A
Cureus; 2023 Nov; 15(11):e49710. PubMed ID: 38161833
[TBL] [Abstract][Full Text] [Related]
8. Recent Research Advances in Double-Strand Break and Mismatch Repair Defects in Prostate Cancer and Potential Clinical Applications.
Jaworski D; Brzoszczyk B; Szylberg Ł
Cells; 2023 May; 12(10):. PubMed ID: 37408208
[TBL] [Abstract][Full Text] [Related]
9. 2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review.
Bergengren O; Pekala KR; Matsoukas K; Fainberg J; Mungovan SF; Bratt O; Bray F; Brawley O; Luckenbaugh AN; Mucci L; Morgan TM; Carlsson SV
Eur Urol; 2023 Aug; 84(2):191-206. PubMed ID: 37202314
[TBL] [Abstract][Full Text] [Related]
10. Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening.
Wei JT; Barocas D; Carlsson S; Coakley F; Eggener S; Etzioni R; Fine SW; Han M; Kim SK; Kirkby E; Konety BR; Miner M; Moses K; Nissenberg MG; Pinto PA; Salami SS; Souter L; Thompson IM; Lin DW
J Urol; 2023 Jul; 210(1):46-53. PubMed ID: 37096582
[TBL] [Abstract][Full Text] [Related]
11. The profile of Black South African men diagnosed with prostate cancer in the Free State, South Africa.
Benedict MOA; Steinberg WJ; Claassen FM; Mofolo N
S Afr Fam Pract (2004); 2023 Jan; 65(1):e1-e10. PubMed ID: 36744484
[TBL] [Abstract][Full Text] [Related]
12. Quality of life and secondary outcomes for open versus robot-assisted radical cystectomy: a double-blinded, randomised feasibility trial.
Vejlgaard M; Maibom SL; Joensen UN; Thind PO; Rohrsted M; Aasvang EK; Kehlet H; Røder MA
World J Urol; 2022 Jul; 40(7):1669-1677. PubMed ID: 35590011
[TBL] [Abstract][Full Text] [Related]
13. A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts.
Ankerst DP; Straubinger J; Selig K; Guerrios L; De Hoedt A; Hernandez J; Liss MA; Leach RJ; Freedland SJ; Kattan MW; Nam R; Haese A; Montorsi F; Boorjian SA; Cooperberg MR; Poyet C; Vertosick E; Vickers AJ
Eur Urol; 2018 Aug; 74(2):197-203. PubMed ID: 29778349
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study.
Lin DW; Newcomb LF; Brown MD; Sjoberg DD; Dong Y; Brooks JD; Carroll PR; Cooperberg M; Dash A; Ellis WJ; Fabrizio M; Gleave ME; Morgan TM; Nelson PS; Thompson IM; Wagner AA; Zheng Y;
Eur Urol; 2017 Sep; 72(3):448-454. PubMed ID: 27889277
[TBL] [Abstract][Full Text] [Related]
15. A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau).
Randazzo M; Müller A; Carlsson S; Eberli D; Huber A; Grobholz R; Manka L; Mortezavi A; Sulser T; Recker F; Kwiatkowski M
BJU Int; 2016 Apr; 117(4):576-83. PubMed ID: 26332304
[TBL] [Abstract][Full Text] [Related]
16. Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators.
Alberts AR; Roobol MJ; Verbeek JFM; Schoots IG; Chiu PK; Osses DF; Tijsterman JD; Beerlage HP; Mannaerts CK; Schimmöller L; Albers P; Arsov C
Eur Urol; 2019 Feb; 75(2):310-318. PubMed ID: 30082150
[TBL] [Abstract][Full Text] [Related]
17. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening.
Assel M; Dahlin A; Ulmert D; Bergh A; Stattin P; Lilja H; Vickers AJ
Eur Urol; 2018 Jun; 73(6):961-967. PubMed ID: 29066048
[TBL] [Abstract][Full Text] [Related]
18. Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort.
Clements MB; Vertosick EA; Guerrios-Rivera L; De Hoedt AM; Hernandez J; Liss MA; Leach RJ; Freedland SJ; Haese A; Montorsi F; Boorjian SA; Poyet C; Ankerst DP; Vickers AJ
Eur Urol; 2022 Aug; 82(2):163-169. PubMed ID: 34980493
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
